CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 730 enrolled
Drug / intervention
Mission Reconnectbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03593772
NCT03593772N/ACompleted

Mission Reconnect: Delivering a Mobile and Web Based Self Directed Complementary and Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD

VA Office of Research and Development·interventional·Posted Jul 20, 2018·Updated Aug 23, 2024

In Brief

A clinical study evaluating Mission Reconnect for PTSD and Chronic Musculoskeletal Pain. Completed, enrolled 730 participants across 3 sites.

Detailed Summary

This project is responsive to Rehabilitation Research and Development's (RR\&D) current special areas of interest for non-pharmacological activity-based interventions for chronic pain impacting pain reduction, function and quality of life. This project aligns with the VA mandate for complementary and integrative health (CIH) care for Veterans and their families. CIH complements traditional care for Veterans managing chronic conditions, such as chronic pain and PTSD. Mission Reconnect (MR) is a user-driven, dyadic, CIH self-care management program delivered remotely that teaches techniques the Veteran/partner dyad can use to reduce pain, anxiety and stress, promote well-being and improve relationship quality. The research goal is to evaluate MR as an approach to manage chronic pain and PTSD symptoms, for potential subsequent implementation. This study will possibly provide a model for establishing remote access and sustainable implementation of CIH within VA.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 20, 2018
Enrollment StartOct 8, 2019
Primary CompletionJul 18, 2022
Study CompletionOct 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 8.0 years ago

Interventions

Mission Reconnectbehavioral

This four-year randomized controlled trial with one intervention arm and one wait-list control arm will utilize mixed methods to evaluate the effectiveness and perceived value of the MR program in relation to physical and psychological symptoms, global health, and social outcomes.